Ayon, Salve S.
HRN: 21-40-64 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2023
CIPROFLOXACIN 500MG (TAB)
05/26/2023
06/02/2023
PO
500mg
BID
Complicated Uti
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes